AC Immune SA Depreciation & Amortization Growth & History (ACIU)
AC Immune SA's depreciation and amortization was CHF2.5M for fiscal 2025.
View full AC Immune SA company overviewAC Immune SA annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | CHF2.5M | CHF341,000 | +15.77% |
| 2024 | 2024-12-31 | CHF2.2M | −CHF53,000 | −2.39% |
| 2023 | 2023-12-31 | CHF2.2M | −CHF144,000 | −6.10% |
| 2022 | 2022-12-31 | CHF2.4M | — | — |
| 2017 | 2017-12-31 | CHF580,000 | CHF302,000 | +108.63% |
| 2016 | 2016-12-31 | CHF278,000 | −CHF9,000 | −3.14% |
| 2015 | 2015-12-31 | CHF287,000 | — | — |
AC Immune SA quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | CHF655,000 | CHF126,000 | +23.82% |
| Q3 2025 | 2025-09-30 | CHF613,000 | — | — |
| Q2 2025 | 2025-06-30 | CHF623,000 | — | — |
| Q1 2025 | 2025-03-31 | CHF612,000 | — | — |
| Q4 2024 | 2024-12-31 | CHF529,000 | — | — |
AC Immune SA depreciation and amortization trends
Between the periods ended 2015-12-31 and 2025-12-31, AC Immune SA's depreciation and amortization increased from CHF287,000 to CHF2.5M, a change of CHF2.2M. The latest reported quarter, Q4 2025, shows CHF655,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA source filings ↗